May Newsmakers

This page will be continuously updated throughout the month of May.

WATCH: Justine Rutter of the Kris Wood Lab explains how understanding genetic tradeoffs with antagonistic pleiotropy informs therapeutic strategies against cancer (JRNL CLUB)

Expert Spotlight: Dr. Andrew Armstrong (The MedNet)

Expert Spotlight: Dr. Christopher Kelsey (The MedNet)

Yousuf Zafar, MD: Comforted by Community (Discover Durham)

Judd W. Moul, MD, FACS, on Triaging Patients with Prostate Cancer (Cancer Network)

Post-Pandemic Predictions About Cancer Disparities After COVID-19
Features Lola Fayanju, MD, MPHS, MA

Duke Researchers To Begin Slowly Returning to Their Labs, With Masks (Duke Today)

COVID-19 Engineering Response Team Assembles from Every Corner of Duke (Pratt School of Engineering)
Features Allan Kirk, MD

WATCH: Celebrating National Nurses Week with DCI (DCI YouTube)

**Duke authors are in bold-type


The dysregulated pharmacology of clinically relevant ESR1 mutants is normalized by ligand-activated WT receptor. Molecular Cancer Therapeutics. May 7, 2020. Kaitlyn J Andreano, Jennifer G Baker, Sunghee Park, Rachid Safi, Sandeep Artham, Steffi Oesterreich, Rinath Jeselsohn, Myles Brown, Sarah Sammons, Suzanne E Wardell, Ching-yi Chang, John D Norris and Donald P McDonnell.

A Phase 1b Dose-Escalation Trial of NC-6300 (Nanoparticle Epirubicin) in Patients with Advanced Solid Tumors or Advanced, Metastatic, or Unresectable Soft Tissue Sarcoma. Clin Cancer Res. 2020 May 7.
Chawla SP, Goel S, Chow W, Braiteh F, Singh AS, Grilley Olson JE, Osada A, Bobe I, Riedel RF.

Incidence of Opioid-Associated Deaths in Cancer Survivors in the United States, 2006-2016A Population Study of the Opioid Epidemic. JAMA Oncology. May 7, 2020. Fumiko Chino, MD; Arif Kamal, MD, MBA, MHS; Junzo Chino, MD.

Environmental Quality and Invasive Breast Cancer. Cancer Epidemiol Biomarkers. April 1, 2020. Gearhart-Serna LM, Hoffman K, Devi GR.

Utilizing Real-World Evidence (RWE) to Improve Care in Chronic Lymphocytic Leukemia: Challenges and Opportunities. Current Hematologic Malignancy Reports. 2020. Prioty Islam & Anthony R. Mato.